Latest Articles
Blossom Ball 2025 - Patient Stories - Endometriosis Foundation of America
Blossom Ball 2025 - Patient Stories Endometriosis Foundation of America
Published: May 14, 2025, 7:34 p.m.
Minister vows to cut endometriosis waitlists - but patients say more action is needed - Edinburgh News
Minister vows to cut endometriosis waitlists - but patients say more action is needed Edinburgh News
Published: May 13, 2025, 2:32 p.m.
Endo the Battle: Health Minister highlights work on endometriosis care - but patients say it 'misses the mark' - Belfast News Letter
Endo the Battle: Health Minister highlights work on endometriosis care - but patients say it 'misses the mark' Belfast News Letter
Published: May 13, 2025, 2:32 p.m.
When doctors dismiss symptoms, patients can suffer lasting harm - Medical Xpress
When doctors dismiss symptoms, patients can suffer lasting harm Medical Xpress
Published: May 12, 2025, 8:57 p.m.
Dismissed Symptoms Lead to Long-Term Patient Harm - Mirage News
Dismissed Symptoms Lead to Long-Term Patient Harm Mirage News
Published: May 12, 2025, 7:40 p.m.
When Doctors Dismiss Symptoms, Patients Suffer Lasting Harm - Rutgers University
When Doctors Dismiss Symptoms, Patients Suffer Lasting Harm Rutgers University
Published: May 12, 2025, 7:24 p.m.
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer - OncLive
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer OncLive
Published: May 12, 2025, 12:39 p.m.
and poor overall patient survival in - ResearchGate
and poor overall patient survival in ResearchGate
Published: May 11, 2025, 2:51 a.m.
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature
Published: May 10, 2025, 10:19 a.m.
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer - OncLive
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer OncLive
Published: May 9, 2025, 11:26 p.m.
Link copied to clipboard!